Inflammatory Choroidal Neovascularization in Pediatric Uveitis: A Case Series
Amandine Gauderon1, Chiara Eandi2, Aikaterini Koryllou3
1Jules-Gonin Eye Hospital, FAA, Uveitis Clinic, Department of Ophthalmology, University of Lausanne, Switzerland.
Summary
Anti-VEGF therapy is safe and effective for treating choroidal neovascularization (CNV) in children with uveitis. Minimal injections are needed, and treating the underlying inflammation is key for good outcomes.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Inflammatory Eye Disease
Background:
- Choroidal neovascularization (CNV) in children is often secondary to ocular inflammation, such as uveitis.
- Understanding the clinical features, treatment, and outcomes of pediatric inflammatory CNV is crucial for effective management.
Purpose of the Study:
- To describe the clinical characteristics, therapeutic interventions, and outcomes of children diagnosed with inflammatory choroidal neovascularization (CNV).
Main Methods:
- A retrospective case series was conducted involving children diagnosed with macular CNV secondary to ocular inflammation.
- Data were collected from patients seen at a specialized eye hospital between 2000 and 2024.
Main Results:
- Four children with inflammatory CNV were identified, presenting with unilateral disease after uveitis onset.
- Treatments included oral steroids, adalimumab, antibiotics, and anti-VEGF injections, with generally good visual acuity outcomes.
- No CNV recurrence was observed, even with uveitis reactivation.
Conclusions:
- Anti-VEGF therapy demonstrates safety and efficacy in pediatric patients with inflammatory CNV, requiring minimal interventions.
- Effective management necessitates addressing the underlying cause of uveitis alongside CNV treatment.
Related Concept Videos
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...


